IBCSG2200_2A | R Documentation |
Kaplan-Meier digitized data from IBCSG2200, figure 2A (PMID 27325862). A reported sample size of 1,086 for a primary endpoint of DFS in breast cancer.
IBCSG2200_2A
A data frame of 1,081 observations and 3 variables:
time | event time (in years) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (cm, no cm) | |
Colleoni M, Gray KP, Gelber S, et al. Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00. J Clin Oncol 2016; 34: 3400–8.
summary(IBCSG2200_2A)
kmplot(IBCSG2200_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.